Bladder EpiCheck kit

Product code: NX899090-01C, NX899090-02C
Producer: Nucleix Ltd.
A kit for the detection of 15 biomarkers for the early detection of bladder cancer by analysis of DNA isolated from urine

More detailed product information

Bladder cancer is the 5th most common type of cancer in men and the 14th in women in the Czech Republic. Unfortunately, this tumor has a high tendency to return, which is why patients are monitored after treatment using unpleasant procedures such as cystoscopy.
The Bladder EpiRcheck test can replace a cystoscopy examination. It is based on the detection of methylation of selected biomarkers by analyzing DNA isolated from urine using the Real-Time PCR method.
Data analysis is completely automatic.

The test is CE-IVD certified.

You can find more information about the product HERE.

For more information, please contact us by e-mail: